Improvement in Expanded Disability Status Scale (EDSS) and anti-inflammatory parameters in patients with multiple sclerosis following oral consumption of N-163 strain of Aureobasidium pullulans produced beta glucan in a pilot clinical study

Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Koji Ichiyama, Naoki Yamamoto, Hiroto Kawashima, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
doi: https://doi.org/10.1101/2023.05.14.23289953

Article usage

Article usage: May 2023 to June 2025

AbstractFullPdf
May 20233731036
Jun 202391618
Jul 202336122
Aug 20231291215
Sep 202329413
Oct 202310956
Nov 202320214
Dec 202336012
Jan 20242049
Feb 202421110
Mar 202433114
Apr 202431724
May 20241327
Jun 20241467
Jul 202418217
Aug 202426122
Sep 202434412
Oct 202415120
Nov 20242308
Dec 202424013
Jan 202526217
Feb 2025362226
Mar 2025583428
Apr 202548126
May 202552630
Jun 20251329
Back to top
Posted May 24, 2023.
Download PDF
Data/Code
Email
Improvement in Expanded Disability Status Scale (EDSS) and anti-inflammatory parameters in patients with multiple sclerosis following oral consumption of N-163 strain of Aureobasidium pullulans produced beta glucan in a pilot clinical study
Vidyasagar Devaprasad Dedeepiya, Chockanathan Vetrievel, Nobunao Ikewaki, Koji Ichiyama, Naoki Yamamoto, Hiroto Kawashima, Sudhakar S Bharatidasan, Subramaniam Srinivasan, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2023.05.14.23289953; doi: https://doi.org/10.1101/2023.05.14.23289953
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area